GIPR and obesity disorder: However, this is not supported by distinct differences in the metabolic phenotype induced by GIPR agonism vs. antagonism in various animal models of obesity-diabetes, with the latter intervention alleviating insulin resistance and inducing β-cell rest [169,272,1014,1015,1022].